Home News

What type of technology is astrazeneca vaccine

Published: 17.06.2022

what type of technology is astrazeneca vaccineThey are made up of comete viruses, but inactivated.

  • Exame of this type of vaccine previously used: injectable poliomyelitis (IPV), influenza.
  • Exames of vaccines against COVID-19 with this tenology: Sinovac Biote, Bharat Biote, Sinopharm, what type of technology is astrazeneca vaccine.

Protein-based vaccines

They are made up of one or more virus proteins or protein fragments, whi generate an immune response.

  • Exame of this type of previously used vaccines: anti-hepatitis B and anti-HPV.
  • Exame of vaccines against COVID-19 with this tenology: Novavax, Medicago.

Vaccines with viral vectors

They use other viruses (for exame, Adenovirus) modified so that they do not cause disease. These viruses carry information for the production of coronavirus proteins, whi trigger the immune response.

  • Exame of this type of vaccines previously used: Ebola vaccines.
  • Exame of vaccines against COVID-19 with this tenology: Sputink V, AstraZeneca/Oxford, Janssen/Johnson & Johnson, CanSinoBio.

Nucleic Acid Vaccines (RNA and DNA)

They use nucleic acids designed by genetic engineering. These vaccines contain the instructions for the production of proteins that trigger the immune response. There are no prior vaccinations with this tenology.

  • Exame of a vaccine against COVID-19 with this tenology: Pfizer/BioNTe, Moderna, Curevac.

Main aracteristics of the vaccines available in Uruguay

Vaccine Platform Dose number Administration Efficacy against symptomatic infection

Most frequent adverse effects

Coronavac Inactivated vaccine 2. Approved for those under 60 years old 0.28 days 50% for symptomatic infection: 100% for severe infection Local reactions (pain, erythema, edema, hardening), pruritus, headae, fatigue, myalgia, nausea, diarrhea, arthralgia, cough, ills, decreased appetite, vomiting, rash, allergic reaction, fever. Less common in older adults. AstraZeneca Viral vector vaccine 2 0.12 weeks 82% Injection site tenderness or pain, fatigue, headae, myalgias, arthralgias, ills, nausea, and fever. Generally of mild or moderate intensity and disappearing a few days after vaccination. You are

Reactions are milder and less frequent after the second dose. Older peoe presented

lower frequency of adverse reactions and mild intensity. Pfizer BioNte RNA vaccine 2 0.28 days 95% Injection site pain, fatigue, headae, myalgia, ills, myalgia, injection site swelling and redness, nausea, malaise, lymphadenopathy, fever. Mostly of mild or moderate intensity and disappearing a few days after vaccination. They are more frequent with the second dose and decrease in probability with age.

Tags

Расчет высокопрочных болтов на растяжение

Особенности расчета на прочность элементов, ослабленных отверстиями под высокопрочные болты:
При статической нагрузке, если ослабление менее 15 °/о, расчет ведется по площади брутто А, а если ослабление больше 15 %—по условной площади Лусл = 1,18 Ап.

Монтажные стыки

Монтажные стыки делают при невозможности транспортирования элементов в целом виде.
Монтажные стыки для удобства сборки устраивают универсальными: все прокатные элементы балки соединяют в одном сечении.

Проверка прочности

Проверка прочности сечения на опоре балки по касательным напряжениям:
Балочной клеткой называется система перекрестных балок, предназначенная для опирания настила при устройстве перекрытия над какой-либо площадью.
rss